Description:

ODM derived from http://clinicaltrials.gov/show/NCT00502840

Link:

http://clinicaltrials.gov/show/NCT00502840

Keywords:
Versions (1) ▾
  1. 12/10/13
Uploaded on:

December 10, 2013

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00502840 Rheumatoid Arthritis

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
age 18 Years to 75 Years
adult patients with rheumatoid arthritis who participated in ML19070, and have completed the week 24 visit
eligible for re-treatment (DAS28 >2.6 after week 24, swollen joint count >=4, tender joint count >=4).
Exclusion Criteria
patients who have withdrawn from treatment in ML19070 pre-week 16
patients with a previous response in DAS28 <0.6 to MabThera after week 16
concurrent treatment with any DMARD except for methotrexate, any TNF alpha inhibitor, or other biologic or investigational agent.